These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 16610787

  • 1. Synthesis and characterization of 3-arylquinazolinone and 3-arylquinazolinethione derivatives as selective estrogen receptor beta modulators.
    Güngör T, Chen Y, Golla R, Ma Z, Corte JR, Northrop JP, Bin B, Dickson JK, Stouch T, Zhou R, Johnson SE, Seethala R, Feyen JH.
    J Med Chem; 2006 Apr 20; 49(8):2440-55. PubMed ID: 16610787
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta.
    Escande A, Pillon A, Servant N, Cravedi JP, Larrea F, Muhn P, Nicolas JC, Cavaillès V, Balaguer P.
    Biochem Pharmacol; 2006 May 14; 71(10):1459-69. PubMed ID: 16554039
    [Abstract] [Full Text] [Related]

  • 3. Pyrazolo[1,5-a]pyrimidines: estrogen receptor ligands possessing estrogen receptor beta antagonist activity.
    Compton DR, Sheng S, Carlson KE, Rebacz NA, Lee IY, Katzenellenbogen BS, Katzenellenbogen JA.
    J Med Chem; 2004 Nov 18; 47(24):5872-93. PubMed ID: 15537344
    [Abstract] [Full Text] [Related]

  • 4. Estrogen receptor subtype-selective ligands: asymmetric synthesis and biological evaluation of cis- and trans-5,11-dialkyl- 5,6,11, 12-tetrahydrochrysenes.
    Meyers MJ, Sun J, Carlson KE, Katzenellenbogen BS, Katzenellenbogen JA.
    J Med Chem; 1999 Jul 01; 42(13):2456-68. PubMed ID: 10395487
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and structure-activity relationship of 3-arylbenzoxazines as selective estrogen receptor beta agonists.
    Yang W, Wang Y, Ma Z, Golla R, Stouch T, Seethala R, Johnson S, Zhou R, Güngör T, Feyen JH, Dickson JK.
    Bioorg Med Chem Lett; 2004 May 03; 14(9):2327-30. PubMed ID: 15081034
    [Abstract] [Full Text] [Related]

  • 6. 6H-Benzo[c]chromen-6-one derivatives as selective ERbeta agonists.
    Sun W, Cama LD, Birzin ET, Warrier S, Locco L, Mosley R, Hammond ML, Rohrer SP.
    Bioorg Med Chem Lett; 2006 Mar 15; 16(6):1468-72. PubMed ID: 16412638
    [Abstract] [Full Text] [Related]

  • 7. Estrogen receptor modulators: identification and structure-activity relationships of potent ERalpha-selective tetrahydroisoquinoline ligands.
    Renaud J, Bischoff SF, Buhl T, Floersheim P, Fournier B, Halleux C, Kallen J, Keller H, Schlaeppi JM, Stark W.
    J Med Chem; 2003 Jul 03; 46(14):2945-57. PubMed ID: 12825935
    [Abstract] [Full Text] [Related]

  • 8. Structural evolutions of salicylaldoximes as selective agonists for estrogen receptor beta.
    Minutolo F, Bertini S, Granchi C, Marchitiello T, Prota G, Rapposelli S, Tuccinardi T, Martinelli A, Gunther JR, Carlson KE, Katzenellenbogen JA, Macchia M.
    J Med Chem; 2009 Feb 12; 52(3):858-67. PubMed ID: 19128016
    [Abstract] [Full Text] [Related]

  • 9. New scaffolds for the design of selective estrogen receptor modulators.
    Martín-Santamaría S, Rodríguez JJ, de Pascual-Teresa S, Gordon S, Bengtsson M, Garrido-Laguna I, Rubio-Viqueira B, López-Casas PP, Hidalgo M, de Pascual-Teresa B, Ramos A.
    Org Biomol Chem; 2008 Oct 07; 6(19):3486-96. PubMed ID: 19082149
    [Abstract] [Full Text] [Related]

  • 10. ERbeta ligands. Part 2: Synthesis and structure-activity relationships of a series of 4-hydroxy-biphenyl-carbaldehyde oxime derivatives.
    Yang C, Edsall R, Harris HA, Zhang X, Manas ES, Mewshaw RE.
    Bioorg Med Chem; 2004 May 15; 12(10):2553-70. PubMed ID: 15110838
    [Abstract] [Full Text] [Related]

  • 11. Synthesis of an estrogen receptor beta-selective radioligand: 5-[18F]fluoro-(2R,3S)-2,3-bis(4-hydroxyphenyl)pentanenitrile and comparison of in vivo distribution with 16alpha-[18F]fluoro-17beta-estradiol.
    Yoo J, Dence CS, Sharp TL, Katzenellenbogen JA, Welch MJ.
    J Med Chem; 2005 Oct 06; 48(20):6366-78. PubMed ID: 16190762
    [Abstract] [Full Text] [Related]

  • 12. Structure-based design of estrogen receptor-beta selective ligands.
    Manas ES, Unwalla RJ, Xu ZB, Malamas MS, Miller CP, Harris HA, Hsiao C, Akopian T, Hum WT, Malakian K, Wolfrom S, Bapat A, Bhat RA, Stahl ML, Somers WS, Alvarez JC.
    J Am Chem Soc; 2004 Nov 24; 126(46):15106-19. PubMed ID: 15548008
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and biochemical characterization of a series of 17α-perfluoroalkylated estradiols as selective ligands for estrogen receptor α.
    Eignerová B, Sedlák D, Dracínský M, Bartunek P, Kotora M.
    J Med Chem; 2010 Oct 14; 53(19):6947-53. PubMed ID: 20812681
    [Abstract] [Full Text] [Related]

  • 14. Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues.
    Meyers MJ, Sun J, Carlson KE, Marriner GA, Katzenellenbogen BS, Katzenellenbogen JA.
    J Med Chem; 2001 Nov 22; 44(24):4230-51. PubMed ID: 11708925
    [Abstract] [Full Text] [Related]

  • 15. Subtle side-chain modifications of the hop phytoestrogen 8-prenylnaringenin result in distinct agonist/antagonist activity profiles for estrogen receptors alpha and beta.
    Roelens F, Heldring N, Dhooge W, Bengtsson M, Comhaire F, Gustafsson JA, Treuter E, De Keukeleire D.
    J Med Chem; 2006 Dec 14; 49(25):7357-65. PubMed ID: 17149865
    [Abstract] [Full Text] [Related]

  • 16. Benzopyrans are selective estrogen receptor beta agonists with novel activity in models of benign prostatic hyperplasia.
    Norman BH, Dodge JA, Richardson TI, Borromeo PS, Lugar CW, Jones SA, Chen K, Wang Y, Durst GL, Barr RJ, Montrose-Rafizadeh C, Osborne HE, Amos RM, Guo S, Boodhoo A, Krishnan V.
    J Med Chem; 2006 Oct 19; 49(21):6155-7. PubMed ID: 17034120
    [Abstract] [Full Text] [Related]

  • 17. Enhanced estrogen receptor beta (ERβ) selectivity of fluorinated carborane-containing ER modulators.
    Ohta K, Ogawa T, Kaise A, Endo Y.
    Bioorg Med Chem Lett; 2013 Dec 15; 23(24):6555-8. PubMed ID: 24268550
    [Abstract] [Full Text] [Related]

  • 18. Benzopyrans as selective estrogen receptor beta agonists (SERBAs). Part 5: Combined A- and C-ring structure-activity relationship studies.
    Richardson TI, Dodge JA, Wang Y, Durbin JD, Krishnan V, Norman BH.
    Bioorg Med Chem Lett; 2007 Oct 15; 17(20):5563-6. PubMed ID: 17804226
    [Abstract] [Full Text] [Related]

  • 19. Insights into ligand selectivity in estrogen receptor isoforms: molecular dynamics simulations and binding free energy calculations.
    Zeng J, Li W, Zhao Y, Liu G, Tang Y, Jiang H.
    J Phys Chem B; 2008 Mar 06; 112(9):2719-26. PubMed ID: 18266357
    [Abstract] [Full Text] [Related]

  • 20. Nonpolar and short side chain groups at C-11beta of estradiol result in antiestrogens.
    Zhang JX, Labaree DC, Hochberg RB.
    J Med Chem; 2005 Mar 10; 48(5):1428-47. PubMed ID: 15743187
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.